Correlation of somatic mutations and clinical outcome in melanoma patients treated with Carboplatin, Paclitaxel, and sorafenib

Correlation of somatic mutations and clinical outcome in melanoma patients treated with Carboplatin, Paclitaxel, and sorafenib

Item
http://www.wikidata.org/entity/Q33758211
Beyond BRAF: where next for melanoma therapy?Copy Number Changes Are Associated with Response to Treatment with Carboplatin, Paclitaxel, and Sorafenib in MelanomaAmuvatinib has cytotoxic effects against NRAS-mutant melanoma but not BRAF-mutant melanoma.In vivo profiling reveals immunomodulatory effects of sorafenib and dacarbazine on melanoma.MicroRNA expression profiling predicts clinical outcome of carboplatin/paclitaxel-based therapy in metastatic melanoma treated on the ECOG-ACRIN trial E2603.Analysis of BRAF and NRAS Mutation Status in Advanced Melanoma Patients Treated with Anti-CTLA-4 Antibodies: Association with Overall Survival?Drug-releasing mesenchymal cells strongly suppress B16 lung metastasis in a syngeneic murine model.Inhibition of Cell Proliferation in an NRAS Mutant Melanoma Cell Line by Combining Sorafenib and α-Mangostin.Identification of a Novel Pathogenic Germline KDR Variant in Melanoma.Real-time tests of multiple genome alterations take the first steps into the clinic: a learning example.Germline determinants of clinical outcome of cutaneous melanoma.Converting biology into clinical benefit: lessons learned from BRAF inhibitors.Emerging growth factor receptor antagonists for the treatment of advanced melanoma.Progress and potential of RAS mutation detection for diagnostics and companion diagnostics.Metastatic Melanoma of Uncertain Primary with 5-Year Durable Response after Conventional Therapy: A Case Report with Literature Review.
P2860

Correlation of somatic mutations and clinical outcome in melanoma patients treated with Carboplatin, Paclitaxel, and sorafenib

Item
http://www.wikidata.org/entity/Q33758211
description
2014 nî lūn-bûn
@nan
2014 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
name
Correlation of somatic mutatio ...... tin, Paclitaxel, and sorafenib
@ast
Correlation of somatic mutatio ...... tin, Paclitaxel, and sorafenib
@en
type
label
Correlation of somatic mutatio ...... tin, Paclitaxel, and sorafenib
@ast
Correlation of somatic mutatio ...... tin, Paclitaxel, and sorafenib
@en
prefLabel
Correlation of somatic mutatio ...... tin, Paclitaxel, and sorafenib
@ast
Correlation of somatic mutatio ...... tin, Paclitaxel, and sorafenib
@en
P1433
P1476
P2093
P2860
P304
P31
P356
P407
P433
P478
P50
P577
P698
P932
P356
P1433
P1476
Correlation of somatic mutatio ...... tin, Paclitaxel, and sorafenib
@en
P2093
P2860
P304
P31
P356
10.1158/1078-0432.CCR-14-0093
P407
P433
P478
P50
P577
P698
P932